Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

NCT05251727 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

77

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG: thrombomodulin alfa
DRUG: Placebo

Sponsor

Veloxis Pharmaceuticals